Literature DB >> 22496324

Extracellular matrix composition in COPD.

Raquel Annoni1, Tatiana Lanças, Ryan Yukimatsu Tanigawa, Marcus de Medeiros Matsushita, Sandra de Morais Fernezlian, Andreina Bruno, Luiz Fernando Ferraz da Silva, Peter J Roughley, Salvatore Battaglia, Marisa Dolhnikoff, Pieter S Hiemstra, Peter J Sterk, Klaus F Rabe, Thais Mauad.   

Abstract

Extracellular matrix (ECM) composition has an important role in determining airway structure. We postulated that ECM lung composition of chronic obstructive pulmonary disease (COPD) patients differs from that observed in smoking and nonsmoking subjects without airflow obstruction. We determined the fractional areas of elastic fibres, type-I, -III and -IV collagen, versican, decorin, biglycan, lumican, fibronectin and tenascin in different compartments of the large and small airways and lung parenchyma in 26 COPD patients, 26 smokers without COPD and 16 nonsmoking control subjects. The fractional area of elastic fibres was higher in non-obstructed smokers than in COPD and nonsmoking controls, in all lung compartments. Type-I collagen fractional area was lower in the large and small airways of COPD patients and in the small airways of non-obstructed smokers than in nonsmokers. Compared with nonsmokers, COPD patients had lower versican fractional area in the parenchyma, higher fibronectin fractional area in small airways and higher tenascin fractional area in large and small airways compartments. In COPD patients, significant correlations were found between elastic fibres and fibronectin and lung function parameters. Alterations of the major ECM components are widespread in all lung compartments of patients with COPD and may contribute to persistent airflow obstruction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496324     DOI: 10.1183/09031936.00192611

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  44 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

Review 2.  Lung extracellular matrix and fibroblast function.

Authors:  Eric S White
Journal:  Ann Am Thorac Soc       Date:  2015-03

3.  Glycosaminoglycans and glycolipids as potential biomarkers in lung cancer.

Authors:  Guoyun Li; Lingyun Li; Eun Ji Joo; Ji Woong Son; Young Jin Kim; Jae Ku Kang; Kyung Bok Lee; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2017-08-18       Impact factor: 2.916

4.  ATF3 and extracellular matrix-related genes associated with the process of chronic obstructive pulmonary.

Authors:  Jia Ye; Li Wen; De-Ling Liu; Guo-xiang Lai
Journal:  Lung       Date:  2014-08-14       Impact factor: 2.584

Review 5.  DAMPs activating innate and adaptive immune responses in COPD.

Authors:  S D Pouwels; I H Heijink; N H T ten Hacken; P Vandenabeele; D V Krysko; M C Nawijn; A J M van Oosterhout
Journal:  Mucosal Immunol       Date:  2013-10-23       Impact factor: 7.313

6.  Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients.

Authors:  Mariana Muñoz-Esquerre; Daniel Huertas; Ignacio Escobar; Marta López-Sánchez; Rosa Penín; Victor Peinado; Joan Albert Barberà; María Molina-Molina; Frederic Manresa; Jordi Dorca; Salud Santos
Journal:  Lung       Date:  2015-03-21       Impact factor: 2.584

7.  The BRD4 inhibitor JQ1 protects against chronic obstructive pulmonary disease in mice by suppressing NF-κB activation.

Authors:  Yan Liu; Zhi-Zhen Huang; Li Min; Zhi-Feng Li; Kui Chen
Journal:  Histol Histopathol       Date:  2020-11-20       Impact factor: 2.303

Review 8.  Matrix Remodeling in Pulmonary Fibrosis and Emphysema.

Authors:  Tejaswini Kulkarni; Philip O'Reilly; Veena B Antony; Amit Gaggar; Victor J Thannickal
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

9.  A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNF-α.

Authors:  Irene M J Eurlings; Mieke A Dentener; Evi M Mercken; Rafael de Cabo; Ken R Bracke; Juanita H J Vernooy; Emiel F M Wouters; Niki L Reynaert
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-08       Impact factor: 5.464

Review 10.  Mesenchymal Stromal Cells to Regenerate Emphysema: On the Horizon?

Authors:  Dennis M L W Kruk; Irene H Heijink; Dirk-Jan Slebos; Wim Timens; Nick H Ten Hacken
Journal:  Respiration       Date:  2018-05-02       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.